Tumor-associated Carbohydrate Antigen, Tn, As A Cancer Prognosis Marker And Therapeutic Target | 28264
Journal of Clinical & Experimental Pathology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Elevated expression of tumor-associated carbohydrate antigens (TACAs) is associated with various cancers. A variety of
malignant and normal tissues have been screened by immunochemistry using antibodies against TACAs. Overexpression
of TATAs (tumor-associated carbohydrate antigens) has been observed on the cell surface of many malignant tumors. The Tn
antigen (GalNAc-Ser/Thr) is one member of TACAs presented as mucin-type carbohydrates. Using the LAE vaccine technology
(Linear Array Epitope), we have developed an anti-Tn vaccine, which induces anti-Tn antibodies with high specificity and
high affinity in mice. Using the anti-Tn antibody, we have demonstrated that the expression of Tn is positively correlated with
the degree of malignancy in prostate, breast, colon, cervical, oral squamous cell carcinoma (OSCC), and pancreas cancers.
In the case of OSCC, the expression of Tn was positively correlated with staging recurrence, and distant metastasis as well
as withinvasive pattern grading score (IPGS). The results suggest that Tn expression may serve as a reliable indicator for
OSCC prognosis evaluation. Our studies have also demonstrated that anti-Tn vaccine can protect against spontaneous prostate
cancer formation in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice. Together, our results show that tumorassociated
carbohydrate antigen, Tn, can serve as a cancer prognosis marker and therapeutic target.
Jaulang Hwang received his PhD in Biological Chemistry from the University of Michigan, Ann Arbor. Dr. Hwang was supervised by Dr. Ira Pastan, NCI, NIH,
for his post doctorate training. He then returned to Taiwan and as an Associate Research Fellow and was later promoted to Research Fellow, at the Institute of
Molecular Biology, Academia Sinica. In addition to his research at Academia Sinica, Dr. Hwang held many roles including: President of Taiwan Genomics and
Genetics Society, Associate-Director of the Institute of Molecular Biology, Academia Sinica, and Dean of the College of Sciences, National Chung Cheng University.
Currently, he is a Distinguished Professor at the Department of Biochemistry, Molecular and Cellular Biology, Taipei Medical University.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals